Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana P Arteaga

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
JCO Oncology Practice|June 27, 2022
Reply to M.Z. Farooq et alDiana P Arteaga, Marcus O Butler
Journal of the National Cancer Institute. Monographs|May 4, 2023
Body composition and endometrial cancer outcomesDiana P Arteaga, Corina DeKraker, Marguerite Ennis, et al.
Journal for Immunotherapy of Cancer|January 23, 2021
Biologic subtypes of melanoma predict survival benefit of combination anti-PD1+anti-CTLA4 immune checkpoint inhibitors versus anti-PD1 monotherapyApril A N Rose, Susan M Armstrong, David Hogg, et al.
Cancers|January 11, 2022
CANDIED: A Pan-Canadian Cohort of Immune Checkpoint Inhibitor-Induced Insulin-Dependent Diabetes MellitusThiago P Muniz, Daniel V Araujo, Kerry J Savage, et al.
Cancer Research Communications|March 2, 2023
Integrated, Longitudinal Analysis of Cell-free DNA in Uveal MelanomaDerek Wong, Ping Luo, Nadia Znassi, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
JCO Oncology Practice|June 27, 2022
Reply to M.Z. Farooq et alDiana P Arteaga, Marcus O Butler
Journal of the National Cancer Institute. Monographs|May 4, 2023
Body composition and endometrial cancer outcomesDiana P Arteaga, Corina DeKraker, Marguerite Ennis, et al.
Journal for Immunotherapy of Cancer|January 23, 2021
Biologic subtypes of melanoma predict survival benefit of combination anti-PD1+anti-CTLA4 immune checkpoint inhibitors versus anti-PD1 monotherapyApril A N Rose, Susan M Armstrong, David Hogg, et al.
Cancers|January 11, 2022
CANDIED: A Pan-Canadian Cohort of Immune Checkpoint Inhibitor-Induced Insulin-Dependent Diabetes MellitusThiago P Muniz, Daniel V Araujo, Kerry J Savage, et al.
Cancer Research Communications|March 2, 2023
Integrated, Longitudinal Analysis of Cell-free DNA in Uveal MelanomaDerek Wong, Ping Luo, Nadia Znassi, et al.
Pageof 1